New Vision-Saving injection tested against standard for blinding eye disease
Disease control
Completed
This study tested if a new eye injection called JL14002 works as well as the standard treatment (ranibizumab/Lucentis) for wet age-related macular degeneration, a leading cause of vision loss in older adults. 443 patients received either the new injection or the standard one ever…
Phase: PHASE3 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC